SBFM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Stats
Today's Volume	31.81M
Average Volume	1.15M
Market Cap	944 803
EPS	$0 ( 2024-04-02 )
Next earnings date	( $-8.00 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500
ATR14	$0.0130 (1.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-04	Slilaty Steve N.	Buy	100 000	Series B Preferred Stock
2024-02-08	Slilaty Steve N.	Buy	20 000	Series B Preferred Stock
2024-01-26	Beaudoin Marc	Buy	0
2022-11-30	Sebaaly Camille	Buy	30 000	Common Stock
2022-10-20	Chamoun Malek	Sell	0	Common Stock, par value $0.001 per share

INSIDER POWER
100.00
Last 67 transactions
Buy: 1 074 426 098 \| Sell: 315 420 609

Volume Correlation

Long: 0.19 (neutral)

Short: 0.90 (strong)

Signal:(34.554) Same movement expected

Sunshine Biopharma, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sunshine Biopharma, Inc. Correlation - Currency/Commodity

0.79
( moderate )

0.70
( moderate )

0.00
( neutral )

0.72
( moderate )

0.00
( neutral )

0.25
( neutral )

Sunshine Biopharma, Inc. Financials

Annual	2023
Revenue:	$24.09M
Gross Profit:	$8.19M (33.99 %)
EPS:	$-0.190

FY	2023
Revenue:	$24.09M
Gross Profit:	$8.19M (33.99 %)
EPS:	$-0.190

FY	2022
Revenue:	$4.35M
Gross Profit:	$1.70M (39.04 %)
EPS:	$-1.760

FY	2021
Revenue:	$228 426
Gross Profit:	$110 596 (48.42 %)
EPS:	$-0.0609

Financial Reports:

No articles found.

Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.